Elisa Radziwill : ein Leben in Liebe und Leid; Unveröffentlichte Briefe der Jahre 1820-1834 /

Mode of access: Internet.

Los varones en el trono : obra política en que se prueba ser preferibles en el gobierno político-civil los hombres que las mujeres y en que se vierten macsimas y consejos para el regimen de la felicidad de una monarquía representativa /

Mode of access: Internet.

Sefer Hadrat Elishaʻ, melitsah meḳorot yeme ha-navi Elishaʻ ben Shafaṭ. Hadrath Elisa, die Lebensgeschichte des Propheten Elisa.

Vocalized.

Un día de prueba : drama original en tres actos y en prosa /

"Representado por primera vez en Madrid, en el teatro de Novedades en abril de 1858" - port.-

Sin prueba plena : comedia en tres actos /

Representada ... en el teatro del Circo

Que es la prueba para anticuerpos del VIH?

In Spanish.

Œuvres complètes d'ʹElisa Mercœur de Nantes : précédées de mémoires et notices sur la vie de l'auteur /

Mode of access: Internet.

Elisa, oder das Weib wie es seyn sollte.

Mode of access: Internet.

Eliza and Claudio, or, Love protected by friendship : a melodrama = Elisa e Claudio, ossia, L'amore protetto dall'amicizia : melodrama semiserio /

English and Italian on opposite pages.

Perlen der heiligen Vorzeit: Helias der Thesbit, Elisa, Die Makkabäer.

Mode of access: Internet.

Performance of commercial enzyme-linked immunosorbent assays (ELISA) for diagnosis of HSV-1 and HSV-2 infection in a clinical setting

Thesis (Master's)--University of Washington, 2016-06

Validation of a novel ELISA for measurement of MDA-LDL in human plasma

The involvement of oxidatively modified low density lipoprotein (LDL) in the development of CHD is widely described. We have produced two antibodies, recognizing the lipid oxidation product malondialdehyde (MDA) on whole LDL or ApoB-100. The antibodies were utilized in the development of an ELISA for quantitation of MDA-LDL in human plasma. Intra- and inter-assay coefficients of variation (% CV) were measured as 4.8 and 7.7%, respectively, and sensitivity of the assay as 0.04 μg/ml MDA-LDL. Recovery of standard MDA-LDL from native LDL was 102%, indicating the ELISA to be specific with no interference from other biomolecules. Further validation of the ELISA was carried out against two established methods for measurement of lipid peroxidation products, MDA by HPLC and F2-isoprostanes by GC-MS. Results indicated that MDA-LDL is formed at a later stage of oxidation than either MDA or F2- isoprostanes. In vivo analysis demonstrated that the ELISA was able to determine steady-state concentrations of plasma MDA-LDL (an end marker of lipid peroxidation). A reference range of 34.3 ± 8.8 μg/ml MDA-LDL was established for healthy individuals. Further, the ELISA was used to show significantly increased plasma MDA-LDL levels in subjects with confirmed ischemic heart disease, and could therefore possibly be of benefit as a diagnostic tool for assessing CHD risk. © 2003 Elsevier Inc.